FDA Approval Status: Wegovy is FDA-approved specifically for weight management, while Tirzepatide (as Mounjaro) was initially approved for type 2 diabetes
Januvia side effects Because Jardiance and Januvia have different mechanisms of action, they tend to cause different adverse effects
Simple Meal Planning Tips to Meet Protein Goals Effective meal planning is the cornerstone of meeting protein targets whilst managing the appetite suppression associated with GLP-1 therapy
Retatrutide is a new, powerful weight loss medication developed by Eli Lilly that simultaneously activates three key receptors: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors
In this study, all RT-qPCR reactions were performed in triplicate with at least three independent biological replicates
Novo Nordisk is working hard to make Wegovy available for patients living with obesity as soon as possible